Literature DB >> 17387264

Why do tumors metastasize?

Miguel López-Lázaro1.   

Abstract

Approximately 90% of all cancer deaths can be attributed to the metastatic spread of primary tumors. An understanding of the process by which cells from a localized tumor invade adjacent tissues and migrate to distant organs is crucial for the development of anticancer strategies that can efficiently prevent this process. Although our knowledge of cancer has increased in recent years, the molecular mechanisms of tumor invasion and metastasis still remain elusive. This report discusses recent data that suggest that tumors metastasize because tumor cells have an alteration in oxygen metabolism (dysoxia). This alteration in oxygen metabolism would drive tumor invasion and metastasis via glycolysis-mediated extracellular acidification, excessive production of hydrogen peroxide (H(2)O(2)) and hypoxia-inducible factor 1 (HIF-1) activation. This new model might help develop cancer chemopreventive strategies for preventing tumor metastasis and thus reduce cancer mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17387264     DOI: 10.4161/cbt.6.2.3950

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  6 in total

1.  Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines.

Authors:  Rajaa Hussien; George A Brooks
Journal:  Physiol Genomics       Date:  2010-12-21       Impact factor: 3.107

Review 2.  A new view of carcinogenesis and an alternative approach to cancer therapy.

Authors:  Miguel López-Lázaro
Journal:  Mol Med       Date:  2009-12-28       Impact factor: 6.354

3.  Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth.

Authors:  Carmela Guido; Diana Whitaker-Menezes; Zhao Lin; Richard G Pestell; Anthony Howell; Teresa A Zimmers; Mathew C Casimiro; Saveria Aquila; Sebastiano Ando'; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Oncotarget       Date:  2012-08

Review 4.  Oxygen-Based Nanocarriers to Modulate Tumor Hypoxia for Ameliorated Anti-Tumor Therapy: Fabrications, Properties, and Future Directions.

Authors:  Xianqiang Li; Yue Wu; Rui Zhang; Wei Bai; Tiantian Ye; Shujun Wang
Journal:  Front Mol Biosci       Date:  2021-07-01

5.  Increasing the endogenous NO level causes catalase inactivation and reactivation of intercellular apoptosis signaling specifically in tumor cells.

Authors:  Georg Bauer
Journal:  Redox Biol       Date:  2015-08-24       Impact factor: 11.799

Review 6.  Cancer cell metabolism: implications for therapeutic targets.

Authors:  Miran Jang; Sung Soo Kim; Jinhwa Lee
Journal:  Exp Mol Med       Date:  2013-10-04       Impact factor: 8.718

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.